Clinical Trial Update: Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Yangzheng Compound Mixture for sleep disorders in cancer patients; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Sleep Disorder

Drugs mentioned

• Yangzheng Compound Mixture

Snippet

Sponsor: ShuGuang Hospital | Conditions: Carcinoma, Sleep Disorder | Phase 4 | Status: ACTIVE_NOT_RECRUITING